Duchenne Muscular Dystrophy Treatments
Find Duchenne Muscular Dystrophy Treatments
Generic Name
Deflazacort
Brand Names
Emflaza, Jaythari, Kymbee, Pyquvi
FDA approval date: September 10, 2018
Classification: Corticosteroid
Form: Tablet, Suspension
What is Emflaza (Deflazacort)?
EMFLAZA is indicated for the treatment of Duchenne muscular dystrophy in patients 2 years of age and older. EMFLAZA is a corticosteroid indicated for the treatment of Duchenne muscular dystrophy in patients 2 years of age and older
Approved To Treat
Top Global Experts
Save this treatment for later
Not sure about your diagnosis?
Tired of the same old research?
Related Clinical Trials
There is no clinical trials being done for this treatment

